Pages that link to "Q37094573"
Jump to navigation
Jump to search
The following pages link to Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma (Q37094573):
Displaying 50 items.
- Structural basis of SUFU-GLI interaction in human Hedgehog signalling regulation (Q24311395) (← links)
- Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation (Q24311603) (← links)
- Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone (Q24595521) (← links)
- New developments in the pathogenesis and therapeutic targeting of the IDH1 mutation in glioma (Q26863394) (← links)
- Lost in translation: animal models and clinical trials in cancer treatment (Q27000792) (← links)
- MicroRNAs in the pathobiology of sarcomas (Q28085250) (← links)
- Molecular pathology of bone tumours: diagnostic implications (Q33275105) (← links)
- α-methylacyl-CoA racemase (AMACR) expression in chordomas differentiates them from chondrosarcomas (Q33275922) (← links)
- Genetic aberrations and molecular biology of skull base chordoma and chondrosarcoma (Q33276468) (← links)
- A pathogenic mosaic TP53 mutation in two germ layers detected by next generation sequencing (Q33583996) (← links)
- Identification of molecular characteristics induced by radiotherapy in rectal cancer based on microarray data. (Q33597819) (← links)
- Recurrent PTPRB and PLCG1 mutations in angiosarcoma (Q33657848) (← links)
- Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma (Q33850534) (← links)
- Myogenic tumors in nevoid Basal cell carcinoma syndrome (Q34022876) (← links)
- Unique mutation portraits and frequent COL2A1 gene alteration in chondrosarcoma (Q34153810) (← links)
- Insertions and Deletions Target Lineage-Defining Genes in Human Cancers (Q34549348) (← links)
- TET proteins and the control of cytosine demethylation in cancer (Q35021377) (← links)
- Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas (Q35075164) (← links)
- The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia (Q35140239) (← links)
- Mutant IDH is sufficient to initiate enchondromatosis in mice (Q35156925) (← links)
- Protein domain-level landscape of cancer-type-specific somatic mutations (Q35203134) (← links)
- Whole exome sequencing of a single osteosarcoma case--integrative analysis with whole transcriptome RNA-seq data. (Q35511058) (← links)
- Mutant IDH1 Dysregulates the Differentiation of Mesenchymal Stem Cells in Association with Gene-Specific Histone Modifications to Cartilage- and Bone-Related Genes (Q35687860) (← links)
- Novel Lys63-linked ubiquitination of IKKβ induces STAT3 signaling (Q36189276) (← links)
- IDH1 R132H Mutation Enhances Cell Migration by Activating AKT-mTOR Signaling Pathway, but Sensitizes Cells to 5-FU Treatment as NADPH and GSH Are Reduced (Q36239445) (← links)
- Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2. (Q37137057) (← links)
- Heterogeneity of genomic evolution and mutational profiles in multiple myeloma (Q37528285) (← links)
- Cancer genomics: why rare is valuable (Q38353573) (← links)
- Highly recurrent H3F3A mutations with additional epigenetic regulator alterations in giant cell tumor of bone (Q38374256) (← links)
- Categorization of cancer through genomic complexity could guide research and management strategies (Q38416477) (← links)
- HES5 silencing is an early and recurrent change in prostate tumourigenesis (Q38923075) (← links)
- An orthotopic mouse model for chondrosarcoma of bone provides an in vivo tool for drug testing (Q38946440) (← links)
- Use of MicroRNA biomarkers to distinguish enchondroma from low-grade chondrosarcoma (Q39706110) (← links)
- Digital PCR analysis of circulating tumor DNA: a biomarker for chondrosarcoma diagnosis, prognostication, and residual disease detection. (Q40498502) (← links)
- IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas (Q41828194) (← links)
- Putting the brakes on chondrosarcoma (Q42666004) (← links)
- TGF-β signalling and PEG10 are mutually exclusive and inhibitory in chondrosarcoma cells (Q42677448) (← links)
- Characterization of Adipose-Derived Stem Cells Following Burn Injury. (Q47101703) (← links)
- The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms. (Q47728815) (← links)
- Biology of Bone Sarcomas and New Therapeutic Developments (Q48120956) (← links)
- Familial solitary chondrosarcoma resulting from germline EXT2 mutation. (Q48280235) (← links)
- Immune checkpoint inhibitors in sarcomas: in quest of predictive biomarkers (Q49859661) (← links)
- Circulating tumour-derived DNA in metastatic soft tissue sarcoma. (Q52356767) (← links)
- IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma. (Q52629240) (← links)
- Genetic alterations in chondrosarcomas - keys to targeted therapies? (Q53070824) (← links)
- Analysis of PD-L1, T-cell infiltrate and HLA expression in chondrosarcoma indicates potential for response to immunotherapy specifically in the dedifferentiated subtype. (Q53083279) (← links)
- Association between Kniest dysplasia and chondrosarcoma in a child. (Q53354589) (← links)
- H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features (Q57022597) (← links)
- Allele balance bias identifies systematic genotyping errors and false disease associations (Q57791634) (← links)
- Chondrosarcoma: biology, genetics, and epigenetics (Q59791226) (← links)